XML 41 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Discontinued Operations and Divestitures (Tables)
6 Months Ended
Jun. 29, 2018
Jun. 30, 2017
Schedule of Income (Loss) from Discontinued Operations  
The following table summarizes the financial results of the Nuclear Imaging business presented in the unaudited condensed consolidated statements of income:
 
Three months ended
 
Six months ended
 
June 30,
2017
 
June 30,
2017
Major line items constituting income from discontinued operations
 
 
 
Net sales
$

 
$
31.6

Cost of sales

 
15.6

Selling, general and administrative expenses

 
7.8

Other

 
(0.2
)
Income from discontinued operations

 
8.4

(Loss) gain on divestiture of discontinued operations
(5.9
)
 
363.4

(Loss) income from discontinued operations, before income taxes
(5.9
)
 
371.8

Income tax (benefit) expense
(0.1
)
 
5.3

(Loss) income from discontinued operations, net of income taxes
$
(5.8
)
 
$
366.5

Specialty Generics Disposal Group    
Schedule of Income (Loss) from Discontinued Operations
The following table summarizes the financial results of the Specialty Generics Disposal Group presented in the unaudited condensed consolidated statements of income:
 
Three Months Ended
 
Six Months Ended
 
June 29,
2018
 
June 30,
2017
 
June 29,
2018
 
June 30,
2017
Major line items constituting income from discontinued operations
 
 
 
 
 
 
 
Net sales
$
193.8

 
$
224.4

 
$
376.5

 
$
475.3

Cost of sales
116.8

 
128.0

 
228.8

 
259.2

Selling, general and administrative expenses
25.6

 
16.2

 
44.4

 
37.3

Research and development expenses
11.3

 
16.9

 
29.2

 
33.7

Restructuring charges, net
0.1

 

 
5.2

 
6.9

Other income, net
0.3

 
2.4

 
0.3

 
3.8

Income from discontinued operations
40.3

 
65.7

 
69.2

 
142.0

Income tax expense
9.0

 
13.5

 
15.8

 
16.0

Income from discontinued operations, net of income taxes
$
31.3

 
$
52.2

 
$
53.4

 
$
126.0


 
Schedule of Major Classes of Assets and Liabiltiies Held For Sale
The following table summarizes the assets and liabilities of the Specialty Generics Disposal Group that are classified as held for sale on the unaudited condensed consolidated balance sheets:
 
June 29,
2018
 
December 29, 2017
Carrying amounts of major classes of assets included as part of discontinued operations
 
 
 
Accounts receivable
$
164.7

 
$
170.4

Inventories
202.1

 
211.7

Property, plant and equipment, net
558.6

 
553.6

Intangible assets, net
112.3

 
114.0

Other current and non-current assets
74.8

 
84.5

Total assets classified as held for sale in the balance sheet
$
1,112.5

 
$
1,134.2

 
 
 
 
Carrying amounts of major classes of liabilities included as part of discontinued operations
 
 
 
Accounts payable
$
40.0

 
$
36.0

Other current and non-current liabilities
130.6

 
126.6

Total liabilities classified as held for sale in the balance sheet
$
170.6

 
$
162.6

 
Schedule of Significant Cash and Non-Cash Transactions
The following table summarizes significant cash and non-cash transactions of the Specialty Generics Disposal Group that are included within the unaudited condensed consolidated statements of cash flows for the respective periods:
 
Three Months Ended
 
Six Months Ended
 
June 29,
2018
 
June 30,
2017
 
June 29,
2018
 
June 30,
2017
Depreciation, including accelerated depreciation
$
2.6

 
$
14.9

 
$
11.5

 
$
30.4

Amortization

 
5.4

 
1.7

 
10.7

Capital expenditures
7.1

 
14.3

 
15.8

 
30.6